Literature DB >> 20952684

Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP.

Abduelhakem Ben Addi1, Dorothée Cammarata, Pamela B Conley, Jean-Marie Boeynaems, Bernard Robaye.   

Abstract

The effects of ADP on the biology of dendritic cells have been studied much less than those of ATP or adenosine. In this study, we showed that adenosine-5'-O-(2-thiodiphosphate) (ADPβS) induced intracellular Ca(2+) transients in murine dendritic cells (DCs). This effect was abolished by AR-C69931MX, a dual P2Y(12) and P2Y(13) receptor antagonist. RT-PCR experiments revealed the expression of both P2Y(12) and P2Y(13) mRNA in DCs. The Ca(2+) response to ADPβS was maintained in P2Y(13)-deficient DCs, whereas it was abolished completely in P2Y(12)(-/-) DCs. ADPβS stimulated FITC-dextran and OVA capture in murine DCs through macropinocytosis, and this effect was abolished in P2Y(12)(-/-) DCs. ADPβS had a similar effect on FITC-dextran uptake by human monocyte-derived DCs. OVA loading in the presence of ADPβS increased the capacity of DCs to stimulate OVA-specific T cells, whereas ADPβS had no effect on the ability of DCs to stimulate allogeneic T cells. Moreover, after immunization against OVA, the serum level of anti-OVA IgG1 was significantly lower in P2Y(12)(-/-) mice than that in wild-type controls. In conclusion, we have shown that the P2Y(12) receptor is expressed in murine DCs and that its activation increased Ag endocytosis by DCs with subsequent enhancement of specific T cell activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952684     DOI: 10.4049/jimmunol.0901799

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

2.  ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation.

Authors:  Monali Manohar; Mark I Hirsh; Yu Chen; Tobias Woehrle; Anjali A Karande; Wolfgang G Junger
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

Review 3.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

Review 4.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

Review 5.  Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines.

Authors:  Sven Nylander; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2016-02-24       Impact factor: 8.739

Review 6.  The role of P2Y₁₂ receptor and activated platelets during inflammation.

Authors:  Elisabetta Liverani; Laurie E Kilpatrick; Alexander Y Tsygankov; Satya P Kunapuli
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

7.  P2Y12 receptor modulation of ADP-evoked intracellular Ca2+ signalling in THP-1 human monocytic cells.

Authors:  J J Micklewright; J A Layhadi; S J Fountain
Journal:  Br J Pharmacol       Date:  2018-04-29       Impact factor: 8.739

8.  ADP exerts P2Y12 -dependent and P2Y12 -independent effects on primary human T cell responses to stimulation.

Authors:  Harika Vemulapalli; Samara Albayati; Viren C Patwa; Douglas G Tilley; Alexander Y Tsygankov; Elisabetta Liverani
Journal:  J Cell Commun Signal       Date:  2019-12-05       Impact factor: 5.782

9.  Lung injury during LPS-induced inflammation occurs independently of the receptor P2Y1.

Authors:  Elisabetta Liverani
Journal:  Purinergic Signal       Date:  2016-11-04       Impact factor: 3.765

10.  Prasugrel metabolites inhibit neutrophil functions.

Authors:  Elisabetta Liverani; Mario C Rico; Analia E Garcia; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  J Pharmacol Exp Ther       Date:  2012-10-24       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.